by Lisa Nadal | Oct 1, 2025 | Events, Scientific
Dr. Emanuele Puca will give an oral presentation entitled: “Antibody-cytokine Fusions for Cancer Therapy: Late-Stage Clinical Results” Dr. Roberto de Luca will give an oral presentation entitled: “Engineering Antibody-Cytokine Fusion Proteins (Immunocytokines) for...by Lisa Nadal | Jun 11, 2025 | Events, Investors
Following last night’s announcement regarding OncoACP3, we are pleased to invite you to a webinar with Prof. Dario Neri, taking place today, June 11, at 11:00 ET | 17:00 CET. Please contact us at IR@philogen.com or follow the link to register to the...by Lisa Nadal | Mar 22, 2025 | Events
Our certified radiation protection experts, Dr. Jacqueline Mock and Dr. Sebastian Oehler, will take part and represent Philochem in the Swiss Radiopharmacy Day.by Lisa Nadal | Mar 22, 2025 | Events, Scientific
Dr. Sebastian Oehler will present Philochem’s recent discovery in the field of prostate cancer under the title “From DNA-Encoded Chemistry to ACP3-Targeted Radioligand Therapeutics against Prostate Cancer” on May 13th (Radiopharmaceutical Therapies track). Follow the...by Lisa Nadal | Mar 22, 2025 | Events, Scientific
Claudia Comacchio is presenting a poster about Philochem’s ACP3 antibody therapeutics on April 29, entitled “Generation and in vivo characterization of a novel antibody targeting Prostatic Acid Phosphatase (ACP-3)” [Abstract Number 4781]. Gudrun Thorhallsdottir is...